Clinical trial
An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension
NCT00454558 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00454558 |
|---|---|
| Title | An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension |
| Official title | A Multicenter, Non-randomized, Non-blinded, Noncontrolled Study to Investigate the Impact of Multiple Doses of BAY 63-2521 on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Pulmonary Hypertension in a 12-week 3 Times a Day Individual Dose Titration Scheme |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension, Pulmonary |
| Intervention type | Drug |
| Interventions | Riociguat (Adempas, BAY63-2521) |
| Enrollment | 75 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2014 |
| Completion | Sep 1, 2014 |
| First posted | Mar 30, 2007 |
| Last update posted | Oct 16, 2015 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: